Organization · Venture Capital
QantX
QantX is a Bristol-based venture capital firm that invests in early-stage, IP-rich startups in the South and South West of England, focusing on sustainability, healthcare modernization, and deep technology.
Overview
What QantX does
What QantX is
QantX is a Bristol-based venture capital firm that invests in early-stage, IP-rich startups in the South and South West of England, focusing on sustainability, healthcare modernization, and deep technology.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- March 31, 2026
Official channels
Find QantX elsewhere
Open the official website or a supported primary organization account.
Capability profile
QantX as a funder
Investment thesis
QantX focuses on investing in early-stage, IP-rich startups in the South and South West of England, targeting innovative solutions in sustainability, healthcare modernization, and deep technology.
Focus narrative
QantX primarily invests in early-stage companies at the Pre-Series A stage, with investment amounts of up to £750,000. The firm targets sectors such as sustainability, healthcare modernization, and deep technology innovation, seeking solutions that tackle global challenges.
Value beyond capital
QantX adds value to its portfolio companies through patient capital, expertise, and connections, particularly leveraging its strong university partnerships to support IP-rich, university-originated startups.
Terms and economics
- Typical check
- $1,000,000
- Sweet spot
- $1,000,000
Focus and fit
- Stages
- Pre-seed · Seed
- Regions
- EuropeUnited Kingdom
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 17
Portfolio context
QantX has partnered with various innovative companies, including Neuronostics, which focuses on neurological conditions; SENISCA, developing therapeutics for unmet medical needs; Ensilitech, providing healthcare solutions; Dynamic Therapeutics, modernizing healthcare practices; Kelpi, promoting sustainability; Light Trace Photonics, engaged in deep tech; Lutra Health, enhancing healthcare delivery; and Xgenera, which develops healthcare solutions.
Common questions
What to know about QantX
Upseed classifies QantX under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
March 31, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.